City and district leaders visited the peak before the festival
Release time:
2020-07-22
cities and districts visited Jianfeng before the festival to express their condolences
. News from our newspaper The Spring Festival is approaching. In recent days, Jinhua Federation of Trade Unions and relevant leaders of Wucheng District have successively visited Jianfeng Group and its subordinate enterprises to express their condolences and send their greetings and wishes for the Spring Festival.
1# October 22 , Chi Xianhong, member of the party group and vice chairman of the Jinhua Federation of Trade Unions, went to Jianfeng Group to visit Fu Deqing, former general manager and vice chairman of the provincial model worker group company, and Jiang Xiaomeng, chairman of the group company, to extend New Year's greetings and greetings to them. Fu Deqing, Jiang Xiaomeng and Vice Chairman Chi Xianhong had a discussion and exchange. Vice Chairman Chi Xianhong affirmed the work of the peak in recent years, and at the same time expressed his gratitude for the contribution that the peak has made to Jinhua and the local economic development. On the morning of
, Wucheng district party Committee secretary Cai Yan and district leaders such as Xu miaofang, Jia hengfei, Zhu Xiaodong and Zhao yanhua visited Jianfeng group. Group leaders Jiang Xiaomeng, Huang Jinlong and Xiang Chongping held discussions and exchanges with Cai Yan and his party. Secretary Cai Yan affirmed the achievements made by Jianfeng in its efforts to innovate, and hoped that Jianfeng would continue to focus on the industry and make persistent efforts to innovate, relying on scientific and technological innovation, management innovation, and R & D innovation to further enhance the core competitiveness of the enterprise, and show new achievements and make new contributions in the new journey of promoting "catching up with and surpassing Wucheng" and implementing the "two-city strategy. On the morning of
1 31 , Zhang Pu, deputy district chief of Wucheng district government, led the district federation of industry and commerce and his party to Jianfeng health technology company to visit dr Li wende, the innovation leader of sssangyong plan. During the discussion, in response to the current hot issues in the health care product industry, Li Wende said that the role of health care products is to improve health conditions. Only by correctly guiding, focusing on research and development, analyzing and grasping the development trend of the biomedicine and health care product market can we be a real health product. leader. Deputy District Mayor Zhang Pu and his entourage said that they have a further understanding of their views on health products and hope that the peak will continue to maintain its momentum and develop steadily. (Ni Yingzhen Xu Feng)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page